Skip to main content
Premium Trial:

Request an Annual Quote

Corning Acquires Cell Culture, Molecular Biology Reagents Firm Mediatech

NEW YORK (GenomeWeb News) – Corning on Thursday said it has completed its purchase of Mediatech for an undisclosed amount.

Mediatech now operates as a wholly owned subsidiary of Corning and will be integrated into Corning Life Sciences. Mediatech's subsidiary KD Medical was included in the deal.

Based in Manassas, Va., Mediatech develops cull culture media and molecular biology reagents for tissue and cell culture applications. Products sold under the cellgro brand include culture media, basal salt solutions, antibiotics, sera, specialty media, and flexible packaging systems.

Its culture media and molecular biology reagents complement Corning's general labware, cell culture, lab equipment, and high-throughput screening/assay products. The acquisition "enables Corning to continue to improve its strategic balance by strengthening its Life Sciences segment," Corning said.

Jason Walsh, director of New Platforms, Corning Life Sciences, will become general manager of Mediatech. James DeOlden, co-founder of Mediatech, will advise the companies during the leadership transition.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.